Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES
No-Receipt date
2025-01316 - 15/04/2025
No-Filing date
20250400791 - 15/04/2025
No-Granting date
3118033 - 29/04/2025
No-EPO application date
19782800.7 - 30/08/2019
No-EPO granting date
3844189 - 22/01/2025
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
4/2025 - 14/05/2025
Expiration date
31/08/2039
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201862726137 P31/08/2018/US
US201862774019 P30/11/2018/US
US201962861100 P13/06/2019/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/573
A61K 39/00
C07K 16/28
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1722504
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
4517196
BROWNSTEIN, CARRIE
4517197
LOWY, ISRAEL
4517198
ADRIAENS, LIEVE LUCILLE
Representatives
Code
Firstname
Surname
Address
Town
Zip
745
CHRISTINA
KIORTSI
SOLONOS 136
ATHINA (ATTIKIS)
10677
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2126
CHRISTINA
KIORTSI
SOLONOS 136
ATHINA (ATTIKIS)
10677
GREECE
Owners History
Title Instruments
Payments history
7 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).